IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 45 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $291,000 | -65.7% | 159,634 | -45.7% | 0.01% | -60.0% |
| Q3 2019 | $849,000 | +43.9% | 293,764 | +33.0% | 0.02% | +53.8% |
| Q2 2019 | $590,000 | +23.4% | 220,803 | +17.8% | 0.01% | +30.0% |
| Q1 2019 | $478,000 | +4.1% | 187,445 | +13.2% | 0.01% | -16.7% |
| Q4 2018 | $459,000 | -64.1% | 165,626 | +12.2% | 0.01% | -55.6% |
| Q3 2018 | $1,280,000 | – | 147,560 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |